Frankfurt - Delayed Quote EUR
Diamyd Medical AB (publ) (DMN.F)
0.8090
+0.0010
+(0.12%)
As of 9:15:34 AM GMT+2. Market Open.
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Operating Cash Flow
-156,174
-129,181
-110,962
-93,219
-109,468
Investing Cash Flow
2,427
-27,994
28,401
-76,722
132,533
Financing Cash Flow
119,035
142,284
86,542
142,155
56,724
End Cash Position
102,436
112,758
127,533
119,761
139,376
Capital Expenditure
-4,423
-8,025
-11,442
-34,652
-4,225
Issuance of Capital Stock
105,317
135,208
75,271
150,000
60,000
Free Cash Flow
-160,597
-137,206
-122,404
-127,871
-113,693
8/31/2021 - 8/28/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
THAR Tharimmune, Inc.
1.4000
-2.10%
CYCN Cyclerion Therapeutics, Inc.
3.0476
-2.32%
TLSA Tiziana Life Sciences Ltd
1.4500
-10.49%
ITRM Iterum Therapeutics plc
0.9396
+0.13%
PHIO Phio Pharmaceuticals Corp.
1.8600
-2.11%
ABEO Abeona Therapeutics Inc.
5.39
-4.26%
BDTX Black Diamond Therapeutics, Inc.
1.8900
-2.07%
KTTA Pasithea Therapeutics Corp.
0.9552
+11.07%
NCNA NuCana plc
0.0346
+5.17%
XLO Xilio Therapeutics, Inc.
0.8500
-26.09%